Complete FDA and NHTSA recall records dated in 2023, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
The recalled product contains undeclared milk, soy, peanuts, tree nuts (almonds, walnuts, pecans, cashews), and sulfites
Parsley imported from Mexico was found to be contaminated with Salmonella
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Short Fill
CGMP Deviations: potential for trace amounts of product carryover.
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Presence of Particulate Matter: Glass particulate matter detected in injectable.
Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product
CGMP Deviations: potential for trace amounts of product carryover.
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product
Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet.
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.
